PATH pushes a unified automation platform as enterprises consolidate tools, supporting ARR growth, stronger pilots and ...

Martin Oswald, Head of Operational Transformation at Travelodge, explains how a deliberate, colleague-first approach to ...

PATH pushes deeper into agentic AI with open standards, new platform tools, and partners, but real payoff may depend on adoption speed and future pricing models.

Morgan Stanley analyst Sanjit Singh also trimmed his price target to $17 from $19. ・Analysts say fourth-quarter results met expectations but see limited near-term upside due to modest growth. ・UBS ...

A detailed overview of the challenges of benefit claims processing in the public sector, and the benefits of applying agentic automation. It highlights issues like complex eligibility criteria and ...

UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...

While conversational AI and agent-based assistants have demonstrated isolated value, scaling AI across the enterprise has remained elusive. Key blockers include security and compliance risks, lack of ...

NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced its UiPath Screen Agent powered by Claude Opus 4.5 achieved a No. 1 ranking on the ...

UiPath, Inc. (NYSE:PATH) is one of the 10 best low-priced AI stocks to buy now. As of March 4, 2026, analyst sentiment remains largely mixed, with UiPath, Inc. (NYSE:PATH) facing pressure amid a 15% ...

UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...